1. [OP.1D.10] THE CKD273 URINARY PROTEOMIC CLASSIFIER IS NOT A MARKER OF GENERALISED VASCULAR DISEASE IN TYPE 2 DIABETIC PATIENTS WITH NORMAL RENAL FUNCTION. (September 2016) Authors: Currie, G.; Flynn, J.; Lindhardt, M.; Mischak, H.; Rossing, P.; Delles, C. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. [OP.4B.04] URINARY PROTEOMICS PREDICTS MORTALITY IN TYPE 2 DIABETES PATIENTS WITH MICROALBUMINURIA. (September 2017) Authors: Currie, G.; Von Scholten, B.J.; Mary, S.; Siwy, J.; Mullen, W.; Rossing, P.; Delles, C. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case‐control study. Issue 10 (2nd June 2018) Authors: Isaksen, J. L.; Graff, C.; Ellervik, C.; Jensen, J. S.; Rossing, P.; Kanters, J. K.; Jensen, M. T. Journal: Diabetic medicine Issue: Volume 35:Issue 10(2018) Page Start: 1337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes. Issue 11 (20th August 2018) Authors: Hansen, C. S.; Theilade, S.; Lajer, M.; Hansen, T. W.; Rossing, P. Journal: Diabetic medicine Issue: Volume 35:Issue 11(2018) Page Start: 1596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characteristics of high‐ and low‐risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes. Issue 10 (6th June 2018) Authors: Tofte, N.; Lindhardt, M.; Adamova, K.; Beige, J.; Beulens, J. W. J.; Birkenfeld, A. L.; Currie, G.; Delles, C.; Dimos, I.; Francová, L.; Frimodt‐Møller, M.; Girman, P.; Göke, R.; Havrdova, T.; Kooy, A.; Mischak, H.; Navis, G.; Nijpels, G.; Noutsou, M.; Ortiz, A. Journal: Diabetic medicine Issue: Volume 35:Issue 10(2018) Page Start: 1375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow‐up study. Issue 11 (6th October 2015) Authors: Rosenlund, S.; Hansen, T. W.; Andersen, S.; Rossing, P. Journal: Diabetic medicine Issue: Volume 32:Issue 11(2015:Nov.) Page Start: 1445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes. Issue 8 (13th April 2015) Authors: Swan, E. J.; Salem, R. M.; Sandholm, N.; Tarnow, L.; Rossing, P.; Lajer, M.; Groop, P. H.; Maxwell, A. P.; McKnight, A. J.; the GENIE Consortium Journal: Diabetic medicine Issue: Volume 32:Issue 8(2015:Aug.) Page Start: 1104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hyperoxia improves autonomic function in individuals with long‐duration type 1 diabetes and macroalbuminuria. Issue 9 (20th May 2020) Authors: Laursen, J. C.; Hansen, C. S.; Bordino, M.; Vistisen, D.; Zobel, E. H.; Winther, S. A.; Groop, P‐H.; Frimodt‐Møller, M.; Bernardi, L.; Rossing, P. Journal: Diabetic medicine Issue: Volume 37:Issue 9(2020) Page Start: 1561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Incident microalbuminuria and complement factor mannan‐binding lectin‐associated protein 19 in people with newly diagnosed type 1 diabetes. Issue 5 (11th April 2017) Authors: Østergaard, J.A.; Thiel, S.; Hoffmann‐Petersen, I.T.; Hovind, P.; Parving, H.‐H.; Tarnow, L.; Rossing, P.; Hansen, T.K. Journal: Diabetes/metabolism research and reviews Issue: Volume 33:Issue 5(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study. Issue 9 (16th October 2020) Authors: Piazza, M.; Hanssen, N. M. J.; Persson, F.; Scheijen, J. L.; van de Waarenburg, M. P. H.; van Greevenbroek, M. M. J.; Rossing, P.; Hovind, P.; Stehouwer, C. D. A.; Parving, H‐H.; Schalkwijk, C. G. Journal: Diabetic medicine Issue: Volume 38:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗